Close
ACHEMA MIDDLE EAST 2026

Lab Bottlenecks? Digitalized Lab Management Systems Can Help

Analytical as well as research laboratories happen to be at the heart of driving scientific breakthroughs in order to address some of the world’s...

UK Research On Crohns Disease Treatment For Better Outcomes

Top-down treatment by way of infliximab Plus, which is an immunomodulator, goes on to substantially enhance the outcomes for patients with newly diagnosed Crohn’s...

Guidance On CAR-T Cell Product Development Issued By FDA

The FDA has gone on to publish its final guidance on January 30, 2024, that goes on to offer consideration for the development of...

Possible Autoimmune Breakthrough With BCMA CAR T Therapy

It is well to be noted that the positive results from the first global study for chimeric antigen receptor (CAR)-antologous T cell- BCMA CAR...

NHSs BRCA Gene Testing Programme To Ascertain Cancer Risk

The BRCA gene testing initiative looks to identify individuals who carry genetic faults associated with an elevated risk of specific cancers, thereby enabling early...

Prescribe Fluoroquinolone Antibiotics As Last Resort – MHRA

It has been determined that fluoroquinolone antibiotics should only be prescribed in cases where no other antibiotics happen to be appropriate for use, as...

2024 Has A Lot Many Questions In Store For Pharma Companies

The advent of powerful new drugs in the case of obesity has gone on to reshape the pharma sector, thereby transforming Eli Lilly as...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...